PL2359816T3 - Formulacje aripiprazolu - Google Patents
Formulacje aripiprazoluInfo
- Publication number
- PL2359816T3 PL2359816T3 PL11153639T PL11153639T PL2359816T3 PL 2359816 T3 PL2359816 T3 PL 2359816T3 PL 11153639 T PL11153639 T PL 11153639T PL 11153639 T PL11153639 T PL 11153639T PL 2359816 T3 PL2359816 T3 PL 2359816T3
- Authority
- PL
- Poland
- Prior art keywords
- aripiprazole formulations
- aripiprazole
- formulations
- Prior art date
Links
- CEUORZQYGODEFX-UHFFFAOYSA-N Aripirazole Chemical compound ClC1=CC=CC(N2CCN(CCCCOC=3C=C4NC(=O)CCC4=CC=3)CC2)=C1Cl CEUORZQYGODEFX-UHFFFAOYSA-N 0.000 title 1
- 229960004372 aripiprazole Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2010/00948A TR201000948A1 (tr) | 2010-02-09 | 2010-02-09 | Aripiprazol formülasyonları. |
EP11153639.7A EP2359816B1 (en) | 2010-02-09 | 2011-02-08 | Aripiprazole formulations |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2359816T3 true PL2359816T3 (pl) | 2017-04-28 |
Family
ID=42551366
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL11153639T PL2359816T3 (pl) | 2010-02-09 | 2011-02-08 | Formulacje aripiprazolu |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP2359816B1 (pl) |
ES (1) | ES2607440T3 (pl) |
PL (1) | PL2359816T3 (pl) |
TR (1) | TR201000948A1 (pl) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JO3753B1 (ar) | 2011-10-14 | 2021-01-31 | Otsuka Pharma Co Ltd | قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه |
WO2013100878A1 (en) * | 2011-12-27 | 2013-07-04 | Mahmut Bilgic | Pharmaceutical formulations comprising aripiprazole |
WO2014104989A1 (en) * | 2011-12-27 | 2014-07-03 | Mahmut Bilgic | Pharmaceutical compositions comprising aripiprazole |
WO2013175508A2 (en) | 2012-05-24 | 2013-11-28 | Medreich Limited | Stable pharmaceutical composition of aripiprazole |
EP3065700A1 (en) * | 2013-11-07 | 2016-09-14 | Synthon B.V. | Orodispersible pharmaceutical compositions comprising aripiprazole |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5006528A (en) | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
WO2003030868A1 (en) * | 2001-10-09 | 2003-04-17 | Bristol-Myers Squibb Company | Flashmelt oral dosage formulation |
MY129350A (en) | 2001-04-25 | 2007-03-30 | Bristol Myers Squibb Co | Aripiprazole oral solution |
JP4310605B2 (ja) | 2001-05-25 | 2009-08-12 | 大塚製薬株式会社 | 医薬用組成物 |
EP1797039A1 (en) | 2004-09-13 | 2007-06-20 | Matrix Laboratories Ltd | Process for the preparation of polymorphs, solvates of aripiprazole using aripiprazole acid salts |
CN101111481A (zh) | 2004-11-18 | 2008-01-23 | 斯索恩有限公司 | 制备结晶阿立哌唑的方法 |
WO2006097344A1 (en) * | 2005-03-17 | 2006-09-21 | Synthon B.V. | Pharmaceutical tablets of crystalline type ii aripiprazole |
CA2614526A1 (en) * | 2005-07-11 | 2006-10-12 | Nycomed Danmark Aps | Benzimidazole formulation |
WO2007035348A2 (en) * | 2005-09-15 | 2007-03-29 | Elan Pharma International, Limited | Nanoparticulate aripiprazole formulations |
ES2325219T3 (es) * | 2006-01-05 | 2009-08-28 | Teva Pharmaceutical Industries Ltd | Formulaciones secas de aripiprazol. |
WO2007113846A1 (en) | 2006-04-03 | 2007-10-11 | Alembic Limited | A process for the preparation of aripiprazole |
EP1880714A1 (en) | 2006-07-20 | 2008-01-23 | Helm AG | Amorphous Aripiprazole and Process for the Preparation thereof |
TR200604349A2 (tr) * | 2006-08-15 | 2008-03-21 | NOBEL İLAÇ SANAYii VE TiCARET A.Ş. | Aripiprazol içeren farmasötik bileşimler |
ES2353444T3 (es) * | 2008-01-23 | 2011-03-02 | Helm Ag | Aripiprazol amorfo y procedimiento para su preparación. |
WO2010079506A2 (en) * | 2008-06-23 | 2010-07-15 | Torrent Pharmaceuticals Ltd. | Pharmaceutical composition of aripiprazole |
-
2010
- 2010-02-09 TR TR2010/00948A patent/TR201000948A1/xx unknown
-
2011
- 2011-02-08 PL PL11153639T patent/PL2359816T3/pl unknown
- 2011-02-08 ES ES11153639.7T patent/ES2607440T3/es active Active
- 2011-02-08 EP EP11153639.7A patent/EP2359816B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
EP2359816A1 (en) | 2011-08-24 |
ES2607440T3 (es) | 2017-03-31 |
TR201000948A1 (tr) | 2011-08-22 |
EP2359816B1 (en) | 2016-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL223206A0 (en) | Vaccine formulations | |
PL2359816T3 (pl) | Formulacje aripiprazolu | |
SG10201602111VA (en) | Formulations Comprising Methylthioninium Chloride | |
ZA201300194B (en) | Formulations | |
GB201110193D0 (en) | Formulations | |
GB201013513D0 (en) | Formulations | |
PL2908859T3 (pl) | Formulacje arypiprazolu | |
GB201110278D0 (en) | Formulations | |
TWM400834U (en) | Otoscopes | |
ZA201300196B (en) | Formulations | |
GB201006326D0 (en) | Formulation | |
GB201018649D0 (en) | Formulations | |
GB201018647D0 (en) | Formulations | |
GB201018645D0 (en) | Formulations | |
GB201018648D0 (en) | Formulations | |
GB201012589D0 (en) | Formulations | |
GB201010494D0 (en) | Formulations | |
GB201008470D0 (en) | Formulations | |
GB201008358D0 (en) | Formulations | |
GB201007959D0 (en) | Formulations | |
GB201007702D0 (en) | Formulations | |
GB201005587D0 (en) | Novel formulations | |
GB201005992D0 (en) | Formulation | |
GB201001978D0 (en) | Formulation | |
GB201002000D0 (en) | Formulation |